Search Results - "Runyon, J P"

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention by Kereiakes, Dean J, Broderick, Thomas M, Roth, Eli M, Whang, David, Shimshak, Thomas, Runyon, John Paul, Hattemer, Charles, Schneider, John, Lacock, Pam, Mueller, Michele, Abbottsmith, Charles W

“…Adjunctive platelet glycoprotein IIb/IIIa blockade during percutaneous coronary intervention (PCI) reduces platelet-mediated adverse ischemic outcomes…”
Get full text

A Rapid Diagnostic and Treatment Center for Patients With Chest Pain in the Emergency Department by Gibler, W.Brian, Runyon, John P, Levy, Richard C, Sayre, Michael R, Kacich, Raymond, Hattemer, Charles R, Hamilton, Cathy, Gerlach, Julie W, Walsh, Richard A

“…See related article, "The Changing Paradigm of Acute Heart Attack Prevention in the Emergency Department: A Futuristic Viewpoint?" Study objective: To evaluate…”
Get full text

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized Trial by KEREIAKES, D. J, KLEIMAN, N. S, HANTSBARGER, G. L, BRYZINSKI, B, TOPOL, E. J, FERGUSON, J. J, ZAKI MASUD, A. R, BRODERICK, T. M, ABBOTTSMITH, C. W, RUNYON, J. P, ANDERSON, L. C, ANDERS, R. J, DREILING, R. J

“…Parenteral administration of platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor blockers can reduce ischemic complications of coronary angioplasty. Orally…”
Get full text

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment by KEREIAKES, D. J, KLEIMAN, N, FERGUSON, J. J, RUNYON, J. P, BRODERICK, T. M, HIGBY, N. A, MARTIN, L. H, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J

“…Inhibition of platelet aggregation with parenteral glycoprotein (GP) IIb/IIIa receptor blockers can reduce the ischemic complications of angioplasty. Sustained…”
Get full text

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab : Administration for complex coronary intervention by KEREIAKES, D. J, RUNYON, J. P, KLEIMAN, N. S, HIGBY, N. A, ANDERSON, L. C, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J

“…Placebo-controlled randomized trials of parenteral platelet glycoprotein (GP) IIb/IIIa receptor antagonists have demonstrated reduced ischemic complications of…”
Get full text

Abciximab provides cost-effective survival advantage in high-volume interventional practice by Kereiakes, Dean J., Obenchain, Robert L., Barber, Beth L., Smith, Andrew, McDonald, Mark, Broderick, Thomas M., Runyon, John Paul, Shimshak, Thomas M., Schneider, John F., Hattemer, Charles R., Roth, Eli M., Whang, David D., Cocks, Douglas, Abbottsmith, Charles W.

“…Background Placebo-controlled randomized trials of platelet glycoprotein (GP) IIb/IIIa blockade during percutaneous coronary intervention have demonstrated…”
Get full text

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management by Dippel, Eric J., Kereiakes, Dean J., Tramuta, Daniel A., Broderick, Thomas M., Shimshak, Thomas M., Roth, Eli M., Hattemer, Charles R., Runyon, John P., Whang, David D., Schneider, John F., Abbottsmith, Charles W.

“…Coronary perforation is an uncommon but potentially life‐threatening complication of percutaneous coronary intervention. The use of both atheroablative…”
Get full text

IIb’s are not IIb’s by Kereiakes, Dean J., Runyon, John Paul, Broderick, Thomas M., Shimshak, Thomas M.

“…Platelet glycoprotein (GP) IIb/IIIa receptor blockade improves clinical outcomes after percutaneous coronary intervention (PCI) and for patients who present…”
Get full text

Ticlopidine monotherapy following coronary stent deployment: "penny wise and pound foolish" by Kereiakes, D J, Young, J J, Runyon, J P, Shimshak, T M

Get more information

Facilitated percutaneous coronary intervention: validating the open artery hypothesis by Runyon, J P

Get more information

Abciximab-associated profound thrombocytopenia : Therapy with immunoglobulin and platelet transfusion by KEREIAKES, D. J, ESSELL, J. H, ABBOTTSMITH, C. W, BRODERICK, T. M, RUNYON, J. P

“…First-time abciximab administration was associated with acute profound thrombocytopenia in 4 of 575 consecutive patients. Therapy with platelet transfusion,…”
Get full text

Serial 12-lead electrocardiographic monitoring in patients presenting to the emergency department with chest pain by Gibler, W B, Sayre, M R, Levy, R C, Runyon, J P, Kacich, R, Hamilton, C, Walsh, R A

Get more information

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization by Topol, E J, Califf, R M, Lincoff, A M, Tcheng, J E

“…New strategies for preventing ischemic complications during percutaneous coronary revascularization have focused on the platelet surface-membrane glycoprotein…”
Get full text

Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty by Investigators, The RESTORE

“…Background Adverse cardiovascular events associated with thrombotic occlusion occur in 4% to 12.8% of patients after coronary angioplasty. Recently, potent…”
Get full text

Rapid dissolution of intracoronary thrombus with eptifibatide therapy in a patient with post-infarction angina by Runyon, J P, Snavely, D D

Get more information

Controller for a remote line concentrator in a time-separation switching experiment by Malthaner, W. A., Runyon, J. P.

“…Remote line concentration, time-separation switching and PCM transmission are combined in a communication system experiment called ESSEX (Experimental Solid…”
Get full text

Extensive thrombus prior to elective percutaneous coronary intervention by Kandzari, D E, Behar, V S, Sketch, Jr, M H, Kereiakes, D J, Shimshak, T, Broderick, T, Young, J, Runyon, J P, Safian, R D, Kern, M, Colombo, A

Get more information

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion by Kereiakes, Dean J., Essell, James H., Abbottsmith, Charles W., Broderick, Thomas M., Runyon, John Paul

“…In summary, first time abciximab administration was associated with acute profound thrombocytopenia in 4 of 575 consecutive patients. Therapy with platelet…”
Get full text

Broadband fiber access : A fiber-to-the-customer access architecture: Optical Networking by BUCHHOLZ, D. B, BYERS, C. C, HINTERLONG, S. J, HUENSCH, G. D, MORRISON, R. L, NANKE, T. R, RUNYON, J. P, YU, H.-C

Get full text

Switched digital video access networks: Two-way broadband access networks by BANKAPUR, R. J, BEUSCHER, H. J, RUNYON, J. P, SANKU, A. C. R, SEHGAL, C. S

Get full text